Tyrosinemia type II is not contagious. It is an inherited metabolic disorder caused by a deficiency of the enzyme tyrosine aminotransferase. This condition is passed down through families in an autosomal recessive pattern. It affects the body's ability to break down the amino acid tyrosine, leading to a buildup of toxic substances. It is important to note that tyrosinemia type II cannot be transmitted from person to person through contact or exposure.
Tyrosinemia type II is not contagious. It is an inherited metabolic disorder that is passed down from parents to their children through genetic mutations. This condition is caused by a deficiency of the enzyme tyrosine aminotransferase (TAT), which is responsible for breaking down the amino acid tyrosine.
Individuals with tyrosinemia type II have difficulty metabolizing tyrosine, leading to a buildup of toxic byproducts in the body. This can result in various symptoms such as intellectual disability, developmental delays, seizures, and liver problems.
The condition is inherited in an autosomal recessive manner, meaning that both parents must carry a mutated gene for their child to be affected. If both parents are carriers, there is a 25% chance with each pregnancy that their child will have tyrosinemia type II.
It is important to note that tyrosinemia type II is not caused by exposure to any infectious agents or environmental factors. It is purely a genetic disorder and cannot be transmitted from person to person.